Lipoprotein and apolipoprotein abnormalities in familial combined hyperlipidemia: A 20-year prospective study

Atherosclerosis

Volumn 159, Issue 2, 2001, Pages 471-481

  McNeely, Marguerite J ^a   Edwards, Karen L ^b   Marcovina, Santica M ^a   Brunzell, John D ^a   Motulsky, Arno G ^a,b   Austin, Melissa A ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Adult; Child; Cholesterol; Familial combined hyperlipidemia; Genetics; Lipoproteins; Triglycerides

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALLELE; ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FAMILIAL HYPERLIPEMIA; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; PARTICLE SIZE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; SCHOOL CHILD; SEX DIFFERENCE;

ADULT; AGE DISTRIBUTION; APOLIPOPROTEIN A-I; APOLIPOPROTEINS; CHILD; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; INCIDENCE; LIPOPROTEINS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PEDIGREE; POLYMORPHISM, GENETIC; PROBABILITY; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK FACTORS; SEX DISTRIBUTION;

EID: 0035204807     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00528-7     Document Type: Article

References (53)

1. Family study of serum lipids and lipoproteins in coronary heart-disease
2. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia
3. Myocardial infarction in the familial forms of hypertriglyceridemia
4. Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23
5. Familial lipoprotein disorders in patients with premature coronary artery disease
6. Genetics of lipoprotein disorders
7. A study of insulin resistance using the minimal model in nondiabetic familial combined hyperlipidemic patients
8. Nonobese patients with familial combined hyperlipidemia are insulin resistant compared with their nonaffected relatives
9. Glucose intolerance in familial combined hyperlipidaemia. EUFAM study group
10. Relationship of insulin sensitivity and apolipoprotein B levels to intra-abdominal fat in subjects with familial combined hyperlipidemia
11. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia
12. LDL physical and chemical properties in familial combined hyperlipidemia
13. Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia
14. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: Normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia
15. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia
16. Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia
17. Low-density lipoprotein subclass patterns and risk of myocardial infarction
18. Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]
19. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women
20. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec cardiovascular study
21. Apolipoprotein E polymorphism in men and women from a Spanish population: Allele frequencies and influence on plasma lipids and apolipoproteins
22. Apolipoprotein E polymorphism in American Indians and its relation to plasma lipoproteins and diabetes. The strong heart study
23. Acute myocardial infarction in young adults: Prognostic role of angiotensin-converting enzyme, angiotensin II type I receptor, apolipoprotein E, endothelial constitutive nitric oxide synthase, and glycoprotein III a genetic polymorphisms at medium-term follow-up
24. Apolipoprotein E genotype: Epsilon32 women are protected while epsilon43 and epsilon44 men are susceptible to ischemic heart disease: The Copenhagen city heart study
25. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM study
26. Apolipoprotein E polymorphism in a French Canadian population of northeastern Quebec: Allele frequencies and effects on blood lipid and lipoprotein levels
27. The relation of apolipoprotein E polymorphism to multiple cardiovascular risk in children: The bogalusa heart study
28. Association of apolipoprotein genetic polymorphisms with plasma cholesterol in a Japanese rural population. The Shibata study
29. Apolipoprotein E polymorphism influences lipid phenotypic expression, but not the low density lipoprotein subfraction distribution in familial combined hyperlipidemia
30. Lipid research clinics program reference values for hyperlipidemia and hypolipidemia
31. Determination of serum glycerides
32. The hyperlipidemic effect of a low-fat, high-carbohydrate diet in diabetic subjects
33. Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a)
34. International federation of clinical chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of international reference material
35. International federation of clinical chemistry standardization project for measurements of apolipoproteins A-I and B. III. Comparability of apolipoprotein A-I values by use of international reference material
36. Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women
37. Simplified isoelectric focusing/immunoblotting determination of apoprotein E phenotype
38. Phenotype expression in familial combined hyperlipidemia
39. The lipid research clinics population studies data book, the prevalence study
40. Apolipoprotein B and AI distributions in the US, 1988-1991: Results of the national health and nutrition examination survey III (NHANES III)
41. A history of hypercholesterolemia influences cholesterol measurements
42. One measurement of serum total cholesterol is enough to predict future levels in healthy postmenopausal women
43. Year-to-year variability of cholesterol levels in a pediatric practice
44. Evaluating cholesterol screening. The importance of controlling for regression to the mean
45. Declining serum total cholesterol levels among US adults. The national health and nutrition examination surveys
46. Day-to-day variability of serum cholesterol, triglyceride, and high-density lipoprotein cholesterol levels. Impact on the assessment of risk according to the national cholesterol education program guidelines
47. Genetic predictors of FCHL in four large pedigrees. Influence of ApoB level major locus predicted genotype and LDL subclass phenotype
48. Segregation analysis of plasma apolipoprotein B levels in familial combined hyperlipidemia
49. Novel genes for familial combined hyperlipidemia
50. Lack of evidence for linkage between low-density lipoprotein subclass phenotypes and the apolipoprotein B locus in familial combined hyperlipidemia
51. Bimodality of plasma apolipoprotein B levels in familial combined hyperlipidemia
52. National cholesterol education program expert panel. Summary of the second report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II)